January 23, 2015
The Cancer Gene Mutation Panel- 50 (CGMP-50) test is a Targeted Next Generation Sequencing (NGS) assay that is used to interrogate the variant status of 50 cancer-related genes in solid tumors including but not limited to Colorectal, Lung, Brain, Ovarian, Thyroid, Breast cancers and Melanomas. The assay is performed on the Ion Torrent Personal Genome Machine (PGM) platform.
CANCER GENE MUTATION PANEL-50 FACT SHEET
CANCER GENE MUTATION PANEL-50 FAQ